The Pune hospital has been directed to submit all details pertaining to the transplant procedure by Monday, Deputy Director of Health Services, Dr Nagnath Yempalle, said on Sunday.
The number of suspected Guillain-Barr Syndrome (GBS) deaths in Pune district, Maharashtra, has reached six after a 63-year-old man died. The outbreak has been linked to water contamination caused by campylobacter jejuni, a common bacterial pathogen that causes gastroenteritis and can trigger GBS. The number of suspected GBS cases has risen to 173, with 140 diagnosed with GBS. 34 patients are in Pune Municipal Corporation limits, 87 from newly added villages in PMC area, 22 from Pimpri Chinchwad civic limits, 22 from rural parts of the district, and eight from other districts. Of the 173, a total of 72 have been discharged, 55 are in ICU and 21 are on ventilator support.
According to the health department, both samples have been sent for whole genome sequencing.
Earlier, 24 deaths were reported at the Dr Shankarrao Chavan Government Medical College and Hospital in Nanded in 24 hours between September 30 and October 1. Twelve of the 24 deceased were infants, a top Maharashtra health department official said on Monday.
Maharashtra has recorded a 17.7 per cent rise in coronavirus cases compared to last week, according to a state health department bulletin.
Don't ignore symptoms like coughing, wheezing or shortness of breath, warns Dr Sandeep Tilve.
An immune-escape Covid-19 strain coupled with the natural spike in influenza and pneumonia cases during winters may lead to a rise in hospitalisation.
The metropolis saw an upward trend in daily COVID-19 cases in the second week of October.
Chief Minister Uddhav Thackeray has instructed officials to take extra efforts to complete the administration of the second dose of anti-COVID-19 vaccines to all eligible people.
Amid mounting concerns over the new 'XE' variant of Covid and a day after the Brihanmumbai Municipal Corporation reported its first case in Mumbai, Maharashtra Health Minister Rajesh Tope on Thursday said the state health department has not received any confirmation about the variant and thus cannot confirm it.
The patients were being administered paracetamol, and not Remdesivir drug, which was used for patients in the first and second COVID-19 waves, they said.
Amid growing concerns over the spurt in COVID-19 cases in China and some other countries, Health Minister Mansukh Mandaviya said the focus is to ensure that no unknown variant of the virus enters India and at the same time there is no impediment to travelling.
The civic body also allowed all the indoor and outdoor games and sports clubs to operate except for swimming and other games where physical contact may take place. They can operate on all seven days as per regular timings, the order said.
State Health Minister Rajesh Tope ordered a probe.
Tope's remarks on the forthcoming drive wherein people above 18 years will become eligible for immunisation came amid reports that many people in Maharashtra are not getting the doses due to the shortage.
Cases with the Omicron variant have already been detected in Karnataka and Gujarat.
Experts said the strain has not propelled a surge in cases like Omicron, but advised strict adherence to COVID-19-appropriate behaviour.
No vaccination against Covid-19 will be held in Mumbai for the next three days as the existing stock of doses has been exhausted, the Brihanmumbai Municipal Corporation (BMC) said on Thursday evening.
'If deaths had been properly reported, it would have helped contain the pandemic.'
'We urge the government to have discussions with private labs on the actual cost of running a test.'
Maruti Phad saw the terrorists kill the Mumbai police officers.
Experts believe that under-reporting is likely to cause an underestimation of the spread of the disease.
In Jaipur, the combination of lopinavir and ritonavir, both second-line HIV drugs, was administered was administered on an elderly Italian couple undergoing treatment for Covid-19 at the SMS Hospital.
© 2026 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances